In a stunning breakthrough, Stanford researchers have unveiled a potential game-changer in the fight against PTSD and traumatic brain injury.

This episode dives deep into the science and promise behind Ibogaine therapy, a powerful plant-based treatment showing an astonishing 86% remission rate for PTSD after just one session. T

he study focused on 30 special forces veterans, exploring a groundbreaking approach known as the MISTIC protocol—Magnesium Ibogaine Therapy for Traumatic Injury to the Central Nervous System.Ibogaine, derived from the African Tabernanthe iboga shrub, interacts with multiple neurotransmitter systems and boosts brain-derived neurotrophic factor, helping the brain to repair itself.

What’s even more compelling? These veterans didn’t just feel better emotionally—they demonstrated significant cognitive improvements, including sharper memory, problem-solving, and focus.

The treatment also showed remarkable safety when paired with magnesium, alleviating concerns about past cardiac risks. While the trial wasn’t placebo-controlled, the neuropsychological improvements were objective and hard to dismiss.

With additional holistic care like breathwork and coaching, this integrative method represents a promising frontier for treating PTSD, depression, and anxiety. It's not yet available in the U.S., but this research could ignite the change.